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Abbreviations: BAZ1A, bromodomain adjacent to zinc-finger 1A; BAZ1B, 
bromodomain adjacent to zinc-finger 1B; CAP-G, chromosome-associated protein G; 
DSB, DNA double-strand break; FBS, fetal bovine serum; FW, forward; HAMMOC, 
hydroxy acid-modified metal oxide chromatography; GAPDH, glyceraldehyde 3-
phosphate dehydrogenase; GFP, green fluorescent protein; IMS, intrinsic metaphase 
structure; ISWI, imitation switch; KIF4A, kinesin family member 4A; KO, knock out; 
NEB, nuclear envelope breakdown; PTS, phase-transfer surfactant; RV, reverse; 
SILAC, stable isotope labeling with amino acids in cell culture; SMARCA5, SWI/SNF-
related matrix-associated actin-dependent regulator of chromatin subfamily A 
member 5; SMC2, structural maintenance of chromosomes protein 2; SNF, sucrose 
non-fermenting protein; TOP2A, DNA topoisomerase IIa; WSTF, William syndrome 
transcription factor; WT, wild type 
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Summary 
In mitosis, chromosomes achieve their characteristic shape through condensation, an 
essential process for proper segregation of the genome during cell division. A classical 
model for mitotic chromosome condensation proposes that non-histone proteins act 
as a structural framework called the chromosome scaffold. The components of the 
chromosome scaffold, such as DNA topoisomerase IIa (TOP2A) and structural 
maintenance of chromosomes protein 2 (SMC2), are necessary to generate stable 
mitotic chromosomes; however, the existence of this scaffold remains controversial. 
The aim of this study was to determine the protein composition of the chromosome 
scaffold. We used the DT40 chicken cell line to isolate mitotic chromosomes and 
extract the associated protein fraction, which could contain the chromosome scaffold. 
MS revealed a novel component of the chromosome scaffold, bromodomain adjacent 
to zinc finger 1B (BAZ1B), which was localized to the mitotic chromosome axis. 
Knocking out BAZ1B caused prophase delay due to altered chromosome condensation 
timing and mitosis progression errors, and the effect was aggravated if BAZ1A, a 
BAZ1B homolog, was simultaneously knocked out; however, protein composition of 
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prometaphase chromosomes was normal. Our results suggest that BAZ1 proteins are 
essential for timely chromosome condensation at mitosis entry. Further 
characterization of the functional role of BAZ1 proteins would provide new insights 
into the timing of chromosome condensation.   
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Introduction 
A major challenge in the field of mitosis research is elucidation of the 
mechanism through which chromosomes achieve the necessary 10,000-fold 
shortening of DNA and thus acquire the characteristic structure essential for proper 
mitosis. A classical model proposes that non-histone proteins act as a structural 
framework during the formation of mitotic chromosomes (1). This “chromosome 
scaffold” was hypothesized to be an insoluble biochemical fraction that could be 
obtained from chromosomes after most of the DNA and proteins were solubilized (2). 
The major components of this fraction are structural maintenance of chromosomes 
protein 2 (SMC2) and DNA topoisomerase IIa (TOP2A) (3), which is thought to affect 
chromosome condensation during late mitosis (4, 5).  
A breakthrough in understanding of the chromosome condensation 
mechanism was the identification of condensin, a pentameric protein complex 
including SMC2 (6-8). The purified chromatin-associated protein complex from 
Xenopus egg extracts, which contains chromosome-associated protein (CAP)-E/SMC2, 
CAP-C/SMC4, CAP-D2, CAP-G, and CAP-H, showed chromosome condensation activity 
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in vitro (6, 9) by introducing positive supercoils into relaxed plasmid DNA in the 
presence of topoisomerase I (9). Furthermore, it has been shown that the condensin 
complex localizes on the mitotic chromosome axis in many vertebrate species (10, 11).  
When the second condensin complex (condensin II: SMC2, SMC4, CAP-D3, 
CAP-G2, and CAP-H2) was discovered, the canonical condensin complex was 
retroactively named condensin I (12). Both condensin complexes localize to the 
mitotic chromosome axis but show alternate distribution (12, 13). Thus, condensin II 
exists predominantly in the nucleus during interphase, whereas condensin I is 
sequestered in the cytoplasm and gains access to chromosomes only after nuclear 
envelope breakdown (NEB) in prometaphase (13). These findings suggest that the 
two condensin complexes act sequentially to initiate the assembly of mitotic 
chromosomes (14, 15). Condensin II is involved in DNA repair during interphase 
through association with several chromosomal proteins and chromosome 
condensation during mitotic entry (13, 16). Moreover, TOP2A and kinesin family 
member 4A (KIF4A), both included in the chromosome scaffold fraction, show 
alternate localization on the mitotic chromosome axis (17, 18). However, the existence 
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and functional significance of such a chromosome scaffold is highly controversial, and 
another widely accepted model proposes that chromosomes are formed solely 
through a hierarchy of chromatin coiling events (19).  
Several studies have demonstrated the involvement of bromodomain 
adjacent to zinc finger 1B (BAZ1B) in heterochromatin remodeling (20, 21). The gene 
encoding BAZ1B is also known as the William syndrome transcription factor (WSTF) 
because of its initial identification as a hemizygously deleted gene in patients with the 
disease (22). BAZ1B may form a complex with the nucleosome-dependent ATPase, 
imitation switch (ISWI)/sucrose non-fermenting protein (SNF)-related matrix-
associated actin-dependent regulator of chromatin subfamily A member 5 (SMARCA5) 
(20, 21). BAZ1B depletion was reported to affect the localization of heterochromatin 
protein 1 (HP1) and histone H3 with trimethylated lysine-9 (HH3-K9me3) (23). 
Furthermore, BAZ1B exhibits tyrosine-protein kinase activity during DNA double-
strand break (DSB) repair by phosphorylating Tyr-142 on histone H2A.X (HH2A.X-
pY142 or g-H2A.X), a protein that recruits the MRN complex, including Mre11, Rad50, 
and Nbs1, during initial DSB processing (24, 25). Moreover, it has now become clear 
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that BAZ1B forms a complex with topoisomerase I and SMARCA5 during the S phase 
and is associated with the progression of DNA replication forks (26). 
In addition, the human genome contains the BAZ1A gene (also named ATP-
utilizing chromatin assembly factor 1, ACF1), which encodes a protein showing 21% 
amino-acid sequence homology with BAZ1B. Similar to BAZ1B, BAZ1A interacts with 
SMARCA5 to form the chromatin accessibility complex (CHRAC), which is required for 
DSB repair through recruitment of Ku proteins in human cells (27). Moreover, BAZ1A 
and BAZ1B were identified in mitotic chromosomes assembled in Xenopus egg 
extracts (14, 28). However, the functions of both BAZ1A and BAZ1B in mitosis remain 
unclear. 
In this study, we used MS to determine the protein composition of the 
chromosome scaffold in chicken DT40 cells. To our knowledge, this is the first 
quantitative proteomic analysis showing that BAZ1B is present in the mitotic 
chromosome scaffold along with previously identified components such as TOP2A, 
SMC2, and KIF4A. Our results suggest that BAZ1B and its homolog BAZ1A co-regulate 
the timing of chromosomal condensation prior to mitotic entry. 
Quantitative proteomics of the mitotic chromosome scaffold	
9	
	
 
Experimental Procedures 
Cell culture 
Chicken DT-40 cells (clone 18) were maintained in Roswell Park Memorial 
Institute (RPMI) 1640 medium (Wako Pure Chemical Industries Ltd., Osaka, Japan) 
supplemented with 10% (v/v) fetal bovine serum (FBS), 1% chicken serum, 100 
U/mL penicillin, and 100 µg/mL streptomycin (Wako Pure Chemical Industries Ltd.) 
at 39°C and 5% CO2 in a humidified incubator. For 13C and 15N labeling of lysine and 
arginine, cells were maintained at 37°C in L-lysine/L-arginine-free RPMI (Thermo 
Fisher Scientific, Waltham, MA, USA) supplemented with 10% (v/v) FBS (Thermo 
Fisher Scientific) dialyzed through a 10,000-molecular-weight cut-off filter, 100 µg/mL 
U-13C615N2-L-lysine:2HCl, 30 µg/mL U-13C615N4-L-arginine:HCl, 100 U/mL penicillin, 
and 100 µg /mL streptomycin (Wako Pure Chemical Industries Ltd.). To obtain 
SMC2OFF cells, SMC2ON/OFF cells were grown in the presence of doxycycline for 30 h 
prior to blocking with nocodazole to inhibit SMC2 expression (11).  
U2OS or HeLa (Kyoto) cells in the exponential growth phase were seeded 
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onto coverslips and grown overnight at 37°C and 5% CO2 in Dulbecco's Modified Eagle 
medium (DMEM, Wako Pure Chemical Industries Ltd.) supplemented with 10% FBS, 
100 U/mL penicillin, and 100 µg/mL streptomycin. 
 
Isolation of mitotic chromosomes 	
DT40 and HeLa cells were incubated with 0.5 µg/mL nocodazole for 13 and 
24 h, respectively, resulting in a mitotic index of 70–90%. Cells were swollen in 
hypotonic buffer containing 40 mM KCl for 5 min and disrupted in polyamine-EDTA 
buffer containing 0.75 mM spermidine, 0.3 mM spermine, 2 mM K-EDTA (pH 7.4) 
(Sigma-Aldrich, St. Louis, MO, USA), and 0.1% digitonin (Biosynth, Staad, 
Switzerland) using a 15-mL Dounce homogenizer (2, 29, 30). Mitotic chromosomes 
were purified by density gradient centrifugation in sucrose (15%, 60%, and 80%) 
and then in Percoll (GE Healthcare Ltd., Buckinghamshire, UK). All buffers used 
contained 1 µg/mL antipain, 1 µg/mL chymostatin, 1 µg/mL leupeptin, 1 µg/mL 
pepstatin A (Peptide Institute, Inc., Osaka, Japan), 1 µg/mL aprotinin, 0.1 mM 
phenylmethylsulfonyl fluoride (Wako Pure Chemical Industries Ltd.), and phosphatase 
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inhibitor cocktails 2 and 3 (1:1,000; Sigma-Aldrich).  
Mitotic chromosomes from three independent preparations were pooled 
together and solubilized in phase-transfer surfactant (PTS) buffer (31).  
 
Isolation of histone-depleted mitotic chromosomes	
Histone-depleted mitotic chromosomes were prepared as previously 
described (2, 29) and transferred to non-EDTA polyamine buffer containing 0.375 mM 
spermidine and 0.03% N,N-dimethyldodecylamine N-oxide. DNA was digested by 
adding 40 µg/mL micrococcal nuclease and 2 mM calcium chloride for 20 min. 
Chromosomes were treated with 0.1 mM copper sulfate under nitrogen gas flow for 
10 min and diluted with an equal volume of 1× TEE buffer (1 mM triethanolamine-
HCl, pH 8.5, and 0.2 mM Na-EDTA). An equal volume of 2× lysis buffer (20 mM Tris-
HCl, pH 9.0, 20 mM Na-EDTA, 0.06% N,N-dimethyldodecylamine N-oxide, and 4 M 
NaCl) was immediately added, and the mixture was incubated for 20 min. The 
histone-depleted mitotic fraction was obtained in the pellet after centrifugation at 
10,000 × g for 5 min.  
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Histone-depleted mitotic chromosomes isolated from mitotic DT40 cells 
grown in heavy SILAC medium were mixed with an equal amount (w/w) of a “mimic” 
histone-depleted mitotic chromosome fraction isolated from a parallel culture in light 
SILAC medium using 1% b-mercaptoethanol, which disrupts the chromosome scaffold, 
resulting in the purification of the background fraction (2, 29). This procedure enabled 
us to perform quantitative comparison between the histone-depleted mitotic 
chromosome fraction and the background because it removed many contaminants 
from the list of potential chromosome scaffold proteins (Fig. S1A). 
 
Trypsin digestion 
Proteins associated with mitotic chromosomes were extracted using PTS (32), 
and 100-µg aliquots were digested with 1 µg endoproteinase Lys-C (Wako Pure 
Chemical Industries Ltd.) and 0.4 µg trypsin (Promega, Fitchburg, WI, USA) in 2 mM 
DTT and 10 mM IAA for 16 h. Digestion was stopped with 1% trifluoroacetic acid 
followed by desalting with an SDB-XC StageTip (33). 
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Mass spectrometry 
The digested peptides or enriched phosphopeptides were analyzed on a Q 
Exactive Hybrid Quadrupole-Orbitrap Mass Spectrometer or an Orbitrap Fusion Tribrid 
Mass Spectrometer (Thermo Fisher Scientific, Bremen, Germany) using the 
acquisition software for the fusion. MS2 spectra were obtained using the Orbitrap 
analyzer on the Orbitrap Fusion Mass Spectrometer. For LC-MS/MS analysis, we used 
a Dionex µ-Precolumn (5 µm particle size, 300 µm inner diameter × 5 mm length) 
and an Acclaim PepMap100 C18 separation column (3 µm particle size, 75 µm inner 
diameter × 150 mm length) as described in a previous report (34). Peptides were 
eluted with a nonlinear gradient of 4–30% buffer B (0.2 % formic acid [FA], 5% DMSO 
in acetonitrile) in buffer A (0.2% FA, 5% DMSO in double-distilled water) applied at a 
flow rate of 250 nL/min over 123 min. After each elution, the column was washed 
with 96% buffer B and re-equilibrated with buffer A. All parameters used in MS 
analysis are shown in Table S1. 
 
Peptide identification and quantification 
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For identification of proteins and phosphorylation sites, peak lists were 
created using Andromeda (35) based on recorded fragmentation spectra searched 
against the Gallus gallus protein database in UniProt (release 2013_07) and our in-
house chicken database. Spectra were also searched against the Homo sapiens 
protein database in UniProt (release 2016_11). Precursor mass tolerance was 10 ppm, 
fragment ion mass tolerance was 0.02 Da, and trypsin specificity was strict (C-
terminal cleavage of Lys or Arg but not before Pro), allowing up to four missed 
cleavages. The results of stable isotope labeling with amino acids in cell culture 
(SILAC) were quantified using MaxQuant 1.4.0.3 or 1.5.6.5. Details of the parameters 
are given in Table S2. MS proteomic data and all other parameters used in MaxQuant 
have been deposited in the ProteomeXchange Consortium 
(http://proteomecentral.proteomexchange.org) via the JPOST partner repository 
(dataset identifiers: PXD007269, PXD008429, and PXD008696) (36-38). All protein 
and phosphopeptide quantification data are also presented in Tables S3–S7. 
 
Plasmid construction 
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The ORFs of human BAZ1A and BAZ1B were amplified by PCR from total cell 
RNA using Superscript II and KOD polymerase and inserted into the entry vector 
(pENTR™ 4 Dual Selection Vector; Thermo Fisher Scientific) between XmnI and NotI 
sites. Vectors for overexpression in human cells were generated via LR clonase-
mediated recombination between the entry vector and pDEST131NGFP (39). The 
pTORA14BAZ1A plasmid for CRISPR-mediated mutagenesis was obtained by inserting 
the double-strand oligo DNA fragment into the AgeI site (blunted by Mung Bean 
Nuclease) of pTORA14 constructed from the U6gRNA-Cas9-2A-GFP plasmid 
(CAS9GFPP-1EA, Sigma-Aldrich). The guide RNA target sequence in the DNA fragment 
was 5′-TCTGTCTCACAAACGGCTTT-3′. 
 
CRISPR-mediated mutagenesis 
HeLa cells were transfected with pTORA14BAZ1A or the SIGMA CRISPR 
plasmid for BAZ1B (guide RNA target sequence 5′-GTGAAGCCGTTGCCCGGAG-3′; 
HS0000488765, Sigma-Aldrich) and sorted based on GFP intensity in a FACSAria II 
flow cytometer (Becton Dickinson, Franklin Lakes, NJ, USA). To extract genomic DNA, 
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sorted cells were resuspended in lysis buffer (50 mM KCl, 10 mM Tris-HCl, pH 9.0, 
0.1% Triton-X 100, 0.4 mg/mL proteinase K) and incubated at 50°C for 3 h. Loci 
targeted by guide RNAs were amplified and sequenced using the following primers:  
forward: 5′-CAGGACGAGAGGAGGTAGGG-3′ and reverse: 5′-
TACCAACCCGCGTTCCCCAC-3′ for BAZ1A KO;  
forward: 5′-AATAATTTCCTCCGGTGCTG-3′ and reverse: 5′-
TCCTCAAGGCCTAAAGCCAAC-3′ for BAZ1B KO. Sequence traces were analyzed by 
tracking indels by decomposition (TIDE) (40). 
 
Immunoblotting 
Proteins were analyzed using the following rabbit primary antibodies: anti-
SMC2 at 1:500 (11), anti-chicken TOP2A at 1:1,000 (41), and anti-BAZ1A at 1:500 
(ab15826; Abcam, Cambridge, UK) and mouse primary antibodies: anti-INCENP at 
1:1,000 (42), anti-human TOP2A at 1:200 (8D2, Medical & Biological Laboratories Co. 
Ltd., Nagoya, Japan), anti-BAZ1B at 1:100 (ab50987; Abcam), and anti-GAPDH at 
1:10,000 (GTX627408; GeneTex Inc., San Antonio, TX, USA). IRDye 800CW donkey 
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anti-rabbit IgG at 1:15,000 (926-32211; Li-COR Biosciences, Lincoln, NE, USA) and 
anti-mouse IgG at 1:15,000 (926-32210; Li-COR Biosciences) were used as 
secondary antibodies. Immune complexes were detected using an Odyssey CLx 
Infrared Imaging System (Li-COR Biosciences) and visualized using Image Studio 5.2 
(Li-COR Biosciences). 
 
Time-lapse fluorescence microscopy 
Wild type (WT) or BAZ1B knockout (KO) HeLa cells were transfected with the 
histone H2B-mRFP fusion protein expression plasmid pRFP-C-H2B using 
Lipofectamine LTX. Stable cell clones expressing the fusion protein were generated 
and maintained in DMEM with 10% FBS, 100 U/mL penicillin, 100 µg/mL streptomycin, 
and 400 µg/mL G418 (074-05963; Wako Pure Chemical Industries Ltd.) at 37°C in a 
5% CO2 atmosphere. For capturing images, cells were grown in 10% FBS-containing 
DMEM without phenol red (044-32955; Wako Pure Chemical Industries Ltd.). Time-
lapse images were acquired every 5 min in a 5% CO2/37°C chamber using a 
BioStation IM system (Nikon, Tokyo, Japan). 
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Drug treatment 
Monastrol (M8515, Sigma), MG132 (474790, Merck, Kenilworth, NJ, USA), 
and RO-3306 (217721, Merck) were dissolved in DMSO and applied to cells at final 
concentrations of 5 µM, 9 µM, and 68 µM for 45 min, 20 h, and 4 h, respectively. To 
release RO-3306 or monastrol, cells arrested by inhibitors were switched to inhibitor-
free medium after washing in this medium three times. 
 
Cell cycle analysis 
HeLa cells fixed in 4% paraformaldehyde (30525-89-4, Wako Pure Chemical 
Industries Ltd.) were probed with an anti-histone H3 S10ph antibody (1:3,000; D2C8, 
Cell Signaling Technology Inc., Danvers, MA, USA) and anti-a-tubulin antibody 
(1:5,000; B-5-1-2, Sigma-Aldrich) and then with Alexa-conjugated secondary 
antibodies; DNA was counterstained with 0.1 µg/mL DAPI. Mitotic cells were identified 
as histone H3 S10ph-positive cells and classified according to chromosomal 
morphology.  
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Mitotic chromosome spread 
The cytospin technique was used to make chromosome spreads with 
preserved chromosome structure. Briefly, mitotic cells were synchronized by 0.1 
µg/mL nocodazole treatment for 12 h and collected by tapping culture dishes. Cells 
were then treated with 75 mM KCl at 37°C for 15 min, and 10,000 cells were deposited 
onto coverslips by centrifugation at 800 rpm for 3 min. 
 
Indirect immunofluorescence microscopy 
After fixing for 7 min in 4% paraformaldehyde, cells were blocked with 1% 
(v/v) BSA in PBS and probed with the following antibodies: anti-Ki-67 at 1:1,000 
(D3B5, Cell Signaling Technology Inc.), anti-NCAP-G at 1:1,000 (gift from Dr. Hirota), 
anti-CAP-H2 at 1:1,000 (CE-024A, Cosmo Bio Co. Ltd., Tokyo, Japan), and anti-TOP2A 
at 1:1,000 (8D2, Medical & Biological Laboratories Co. Ltd.). Cells were washed three 
times with PBS for 5 min before adding Alexa-conjugated secondary antibodies 
(Thermo Fisher Scientific) at 1:600; DNA was counterstained with 0.1 µg/mL DAPI. 
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Single focal plane images were obtained under an Olympus FV1000 microscope (IX81 
confocal microscope system with a UPlan SApo 60×/1.35 oil-immersion objective 
lens; Olympus, Tokyo, Japan). FV10-ASW2.1 was used for visualization (Olympus), 
and images were Kalman-filtered to reduce noise.  
 
Experimental design and statistical rationale  
Mitotic chromosomes were isolated from chicken cells or human cells treated 
with nocodazole after six cell divisions to incorporate labeled arginine and lysine. Each 
sample for MS analysis was generated by combining three individual preparations of 
isolated mitotic chromosomes or mitotic chromosome scaffolds; two biological 
replicates for each cell type were analyzed. LC-MS/MS data were searched against 
UniProt database using MaxQuant 1.5.6.5 and statistically evaluated using one 
sample test in Perseus 1.6.1.3 (43). Continuous variables were expressed as the mean 
± SD, variance was evaluated by F-test, and the significance of the results was 
analyzed by Welch's t-test in R. Differences were considered significant at p ≤ 0.05. 
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RESULTS 
Protein composition of the mitotic chromosome scaffold 
Previously, we reported that SILAC ratios were useful for distinguishing 
chromosomal protein classes (30). Here, we demonstrated their utility for identifying 
chromosome scaffold proteins. It was shown that mitotic chromosome scaffold 
proteins such as ScI (TOP2A) and ScII (SMC2) were accumulated in the fraction of 
histone-depleted mitotic chromosomes (29) and that the addition of 1% b-
mercaptoethanol dissociated the chromosome scaffold (Fig. 1A) (2, 29). Therefore, to 
obtain accurate results, we compared proteins in the isolated scaffold with those in 
the background obtained by chromosome scaffold isolation with 1% b-
mercaptoethanol. This procedure allowed removal of many contaminating proteins 
from the list of putative chromosome scaffold proteins (forward [FW] label: lysine-8 
and arginine-10 [heavy] – chromosome scaffold; lysine-0 and arginine-0 [light] – 
background; Fig. S1A–D).  
To examine reproducibility of the results, we used the same strategy with 
alternative labeling (reverse [RV] label: heavy – background, light – chromosome 
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scaffold). Accordingly, 786 proteins could be quantified more than once in the FW and 
RV labeling experiments. Labeling revealed that TOP2A, KIF4A, condensin subunits, 
PLK1 (a condensation regulation factor localized to the chromosome axis) (44), and 
BAZ1B were highly concentrated in the mitotic chromosome scaffold fraction (Fig. 1B, 
Table S3). 
 
Proteins enriched in the mitotic chromosome scaffold versus mitotic 
chromosomes 
We expected that core components of the chromosome scaffold, such as 
TOP2A and SMC2, should be more concentrated in the mitotic chromosome scaffold 
(insoluble) fraction compared to the soluble fraction from which the chromosome 
scaffold was removed. Therefore, we combined histone-depleted mitotic 
chromosomes from DT40 cells grown in heavy SILAC medium with an equal protein 
amount of the soluble fraction from a parallel culture grown in light SILAC medium 
(FW label; RV labeling was performed to investigate reproducibility; Fig. 1A, S1E). As 
a result, 739 proteins could be quantified more than once in the FW and RV 
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experiments. Ranking these proteins according to their enrichment in the 
chromosome scaffold fraction revealed that not only condensin subunits and TOP2A 
but also several centromere/kinetochore proteins were enriched in the chromosome 
scaffold, whereas condensin II subunits were less abundant (Fig. 1C). Furthermore, 
BAZ1B was as enriched as other scaffold components in histone-depleted mitotic 
chromosomes (Fig. 1C). Interestingly, even core histones were not observed in the 
histone-depleted mitotic chromosome fraction (Fig. 1A, C); however, we detected 
anomalous levels of histone macroH2A (Fig. 1C, S1F), which could possibly be 
involved in linking histones and chromosome scaffolds during chromosome 
condensation.  
 
Protein composition in histone-depleted mitotic chromosomes of SMC2ON and 
SMC2OFF cells 
SMC2 is essential for the formation of the mitotic chromosome scaffold (11). 
Therefore, we used the histone-depleted mitotic chromosome fraction isolated from 
SMC2 KO cells as a possible second background fraction. Previously, we compared 
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protein composition in mitotic chromosomes of SMC2ON and SMC2OFF cells (45). Here, 
we assessed protein abundance in histone-depleted mitotic chromosomes obtained 
from cells expressing SMC2 or not. For this, we combined equal amounts of histone-
depleted mitotic chromosomes isolated from SMC2ON cells in heavy SILAC medium 
and SMC2OFF cells in light SILAC medium (Fig. S2A). Consistent with the results of the 
previous experiment, TOP2A, KIF4A, and condensin subunits were not concentrated 
in histone-depleted mitotic chromosomes from SMC2OFF cells; however, BAZ1B was 
concentrated (Fig. S2B, C). This finding suggests that, unlike other scaffold proteins, 
BAZ1B associates with the chromosome scaffold independently of condensin. 
 
BAZ1B localizes to the mitotic chromosome axis 
To validate our quantitative proteomic data, we isolated histone-depleted 
mitotic chromosomes (chromosome scaffolds) from HeLa cells and assessed the levels 
of BAZ1B by immunoblotting (Fig. 1D). Furthermore, to ensure that important protein 
mechanisms were conserved, we expressed GFP-tagged human BAZ1B in human 
epithelial U2OS cells and assessed its localization during mitosis. A previous study 
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showed localization of GFP-tagged condensin subunits SMC2-GFP, CAP-H:GFP, and 
CAP-D:GFP to the chromosome axis (18). In the control experiment, GFP-b-
glucuronidase did not show any specific localization on mitotic chromosomes (Fig. 1E), 
whereas GFP-BAZ1B was confirmed to be localized to the chromosome axis (Fig. 1F), 
strongly suggesting that BAZ1B is associated with the chromosome scaffold during 
mitosis. Moreover, GFP signals were stronger in the centromeric and telomeric regions 
on the chromosome axis (Fig. 1F), indicating that BAZ1B localizes preferentially to 
the heterochromatin region.  
 
BAZ1 deficiency alters progression through mitosis 
 To investigate whether BAZ1B plays a functional role in mitotic chromosomes, 
we generated mutant BAZ1B KO HeLa cells using CRISPR/Cas9; the lack of 
endogenous BAZ1B was confirmed by immunoblotting and DNA sequencing (Fig. 2A, 
S3A). Compared to WT cells, BAZ1B KO cells grew only slightly slower (Fig. 2B, S3B), 
which prompted us to investigate why BAZ1B KO cells were not more affected despite 
the known localization of BAZ1B to the chromosome axis. For this, we examined the 
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role of BAZ1B homolog BAZ1A by generating BAZ1A KO cells and BAZ1A/BAZ1B 
double-KO cells lacking endogenous BAZ1A or both BAZ1 proteins, respectively (Fig. 
2A, S3C). BAZ1 and BAZ1B share the same structure and interact with each other 
and with SMARCA5 (21, 46); however, BAZ1A has two instead of three WSTF-HB1-
Itc1p-MBD9 (WHIM) DNA-binding domains (Fig. 2C). Similar to BAZ1B, GFP-BAZ1A 
was confirmed to be present in the nuclei in interphase (Fig. S4A, B), but it was 
difficult to detect its localization to the chromosomes and chromosomal axis in mitosis 
(Fig. S4C). Nonetheless, immunoblotting clearly showed that BAZ1A existed in 
isolated mitotic chromosomes but not in chromosome scaffolds (Fig. 1D). BAZ1A KO 
and WT cells exhibited similar growth; however, BAZ1A/B double-KO cells grew 
significantly slower than WT cells, but GFP-BAZ1B overexpression partially restored 
normal growth in double-KO cells (Fig. 2B, S3B). Mitotic profiles revealed that the 
percentage of cells at prometaphase tended to be higher in the double-KO group 
(47%) compared to the WT group (37%); at the same time, the proportion of cells 
at anaphase and telophase decreased in the double-KO group compared to the WT 
group (7% versus 13% in anaphase and 9% versus 15% in telophase, respectively; 
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Fig. 2D). However, GFP-BAZ1B overexpression partially restored segregation in 
double-KO cells (Fig. 2D). On the other hand, BAZ1A KO or BAZ1B KO cells did not 
show significant changes in the mitotic profile compared to WT cells (Fig. 2D). 
Therefore, to focus on the delay of chromosome alignment in double-KO cells, we 
next analyzed prometaphase arrest by synchronizing cells at the prometaphase stage 
by monastrol treatment for 4 h and then placing them into monastrol-free medium 
supplemented with MG132. Monastrol treatment led to the arrest of approximately 
15% of total cells that were in mitosis, 80% of which were in early prometaphase 
(Fig. 2E). However, after 1 h in monastrol-free medium, the percentages of BAZ1B 
KO and BAZ1A/B double-KO cells in early prometaphase were significantly higher 
compared to that of WT cells (42% and 56% versus 21%, respectively), whereas the 
percentages of cells in metaphase were significantly lower (31% and 17% versus 
63%, respectively; Fig. 2E). At the same time, no significant differences were 
observed between BAZ1A KO and WT cells (Fig. 2E). These results suggest that 
although BAZ1B is important for mitosis progression, endogenous BAZ1A alleviates 
the BAZ1B KO phenotype, whereas	BAZ1A/B double-KO aggravates it.  
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Segregation errors were detected in less than 6% of WT, BAZ1A KO, and 
BAZ1B KO cells but in 15% of double-KO cells (Fig. 2F, G); however, GFP-BAZ1B 
overexpression partially restored segregation in double-KO cells (Fig. 2F). It has been 
shown that segregation errors are frequently observed in cells deficient in condensin 
I or II, which are localized to the mitotic chromosome axis (13, 47, 48), suggesting 
that BAZ1 proteins may perform a similar function. Furthermore, time-lapse imaging 
of histone H2B-mRFP-expressing cells showed a slight increase in the time between 
estimated NEB and anaphase onset in double-KO cells (33.8 min) compared to WT, 
BAZ1A KO, and BAZ1B KO cells (28.6, 29.8, and 29.4 min, respectively; Fig. 2H, I 
and Supplemental movie 1–5). Furthermore, double-KO cells showed a significant 
increase in segregation errors at anaphase compared to WT cells (22.6% versus 1.5%, 
respectively; Fig. 2I, J).  
Interestingly, the percentage of double-KO cells in prophase increased 
significantly following monastrol treatment, which was also observed in non-
synchronized cells (Fig. 2D, E), although the difference was not significant. 
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BAZ1 deficiency causes mitotic entry delay 
We further investigated the prophase delay in BAZ1A/B double-KO cells by 
immunofluorescence using the anti-histone H3 phospho-serine 10 (H3pS10) antibody 
and DAPI to visualize chromosome morphology before NEB. However, 
phosphorylation of histone H3 occurs and is completed in the preceding prophase (49, 
50). Therefore, it should be noted that two types of chromosome morphology could 
be present in prophase in this study: relaxed chromosomes marking early prophase 
and condensed chromosomes marking late prophase (Fig. 3A-C). Late prophase, in 
which individual condensed chromosomes could be clearly recognized, was 
distinguishable from early prophase; however, about 34% of cells had chromosomes 
of both types, marking the third type: middle prophase (Fig. 3A-C). The percentage 
of WT cells in early prophase (36%) was lower, whereas that in late prophase (30%) 
was significantly higher compared with those of BAZ1A/B double-KO cells (58% and 
18%, respectively), and a similar tendency was observed for BAZ1B KO cells (Fig. 
3D). 
 We then investigated whether prophase delay occurred in synchronized cells. 
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WT or KO cells were arrested in the G2 phase using the Cdk 1 inhibitor RO-3306 (51), 
and prophase profiles were observed 10, 20, or 30 min after switching to RO-3306-
free medium. At 10 min, 90% of all cells were in early prophase; however, at 20 and 
30 min, there were significantly more cells at early prophase in BAZ1B KO or BAZ1A/B 
KO groups compared to WT (Fig. 3E). At the same time, there were significantly fewer 
cells in middle prophase for the BAZ1A/B KO group and in late prophase for both 
BAZ1A/B KO and BAZ1B KO groups compared to WT at 30 min after RO-3306 release 
(Fig. 3E). These results indicate that the absence of BAZ1B delays chromosome 
condensation onset, and the effect is further aggravated if BAZ1A is absent as well, 
suggesting that BAZ1A and BAZ1B might co-regulate the chromosomal condensation 
timing at early prophase. 
 
Proteomics analysis of mitotic chromosomes lacking BAZ1 proteins 
To further elucidate the role of BAZ1 in mitotic chromosomes, we compared 
the association of all chromosomal proteins with mitotic chromosomes in cells with 
and without BAZ1B or BAZ1A/B using our previously developed quantitative 
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proteomic approach (30, 52, 53). Mitotic chromosomes were isolated after mixing 
equal amounts of WT cells cultured with lysine-8 and arginine-10 (heavy) and BAZ1B 
KO or BAZ1A/B double-KO cells cultured with lysine-0 and arginine-0 (light) (Fig. 
S5A), and their proteomes were analyzed by MS. A total of 1,243 and 1,290 proteins 
were identified based on comparison between WT and BAZ1B KO or BAZ1A/B double-
KO cells, respectively, in two separate experiments. 
The lack of BAZ1B decreased the association of SMARCA5 with mitotic 
chromosomes in BAZ1B KO cells to ~30% of that in WT (Fig. 4A). Given that 
SMARCA5 interacts with BAZ1B in the S phase, our results indicate that the SMARCA5-
chromosome association depends on BAZ1B. Moreover, although topoisomerase I is 
part of the BAZ1B/SMARCA5 complex in the S phase (26), its association with mitotic 
chromosomes was unchanged in BAZ1B KO or BAZ1A/B double-KO cells compared to 
that in WT cells, suggesting that topoisomerase I associates with chromosomes 
through the BAZ1B/SMARCA5 complex independently of BAZ1B (Fig. 4A, B).  
No dramatic changes were observed in the mitotic chromosome scaffold 
components (condensin I and II, TOP2A, and KIF4A) in BAZ1A/B double-KO cells (Fig. 
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4B), suggesting that their association with mitotic chromosomes does not depend on 
BAZ1 proteins. Ki-67, a component of the mitotic chromosome periphery and one of 
the most abundant proteins in mitotic chromosomes (30) that regulates their 
organization via interaction with protein phosphatase 1 (PP1) (54), showed a tendency 
to decrease in BAZ1A/B double-KO cells compared with WT; however, the changes 
did not reach statistical significance in a volcano plot (Fig. 4B). Moreover, 
immunofluorescence staining with anti-Ki-67 antibodies did not reveal significant 
differences between WT and BAZ1A/B double-KO cells (Fig. 4C, D).  
In addition, we analyzed protein phosphorylation in mitotic chromosomes by 
enriching for phosphopeptides using TiO2-based HAMMOC (32, 55) and subjecting 
them to LC-MS/MS (Fig. S5A). In SILAC experiments comparing WT and BAZ1B KO 
cells or WT and BAZ1A/B double-KO cells, we identified 1,536 or 1,446 
phosphorylation sites in proteins associated with isolated mitotic chromosomes, 
respectively. However, we were unable to identify phosphorylation sites directly 
targeted by BAZ1B or BAZ1A in mitotic chromosomes, even though the 
phosphorylation of chromosomal proteins was mildly reduced in BAZ1A/B double-KO 
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cells (Fig. S5B, C).  
 
Mitotic chromosome axes remain intact in BAZ1A/B double-KO cells 
Although the lack of BAZ1A/B resulted in a mild phenotype characterized by 
aberrant chromosome structure in prometaphase, we did not observe morphological 
abnormalities in mitotic KO cells after visualization of the chromosome axis and its 
components by immunofluorescence (Fig. 4E). Next, we quantified CAP-G, CAP-H2, 
and TOP2A in mitotic chromosome axes of KO cells relative to co-spread HeLa cells 
overexpressing histone H2B-mRFP fusion protein; the design of the experiment is 
shown in Fig. 4F. The presence of CAP-G and CAP-H2 was unchanged in all KO cells, 
whereas that of TOP2A tended to increase in double-KO cells compared to WT cells 
(Fig. 4G). These results suggest that BAZ1A and BAZ1B did not significantly affect 
chromosome axes in prometaphase. 
To confirm a weak effect of BAZ1A and BAZ1B depletion on mitotic 
chromosome structure, we performed an intrinsic metaphase structure (IMS) assay 
(Fig. S6A-C), in which chromosome unfolding to 10-nm structures is induced by 
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removal of divalent cations, and then refolding is induced by Mg2+ addition (54, 56). 
Consistent with previous reports that mitotic chromosomes lacking SMC2 or KIF4A 
were severely impaired in the IMS assay even though they appeared morphologically 
normal (11, 18), we observed the same effect in chicken DT40 cells (Fig. S6B). Our 
experiment clearly showed that chromosomes in ~90% of BAZ1A or BAZ1B KO cells 
efficiently regained their normal morphology after the unfolding-refolding cycle (Fig. 
S6C), suggesting that BAZ1A and BAZ1B are not individually required for maintaining 
the intrinsic structure of mitotic chromosomes. Moreover, mitotic chromosomes 
lacking both BAZ1A and BAZ1B were slightly affected as evidenced by the fact that 
80% of double-KO cells regained normal chromosome morphology, and GFP-BAZ1B 
transfection partially rescued this phenotype (Fig. S6C). The effect of BAZ1A/BAZ1B 
KO was significantly weaker compared to SMC2 KO in DT40 cells, suggesting that 
mitotic chromosomes retained their structure in synchronized prophase irrespectively 
of BAZ1A/B presence.  
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Discussion 
Components of the chromosome scaffold play an important role in the 
formation of structurally stable mitotic chromosomes. In this study, we used MS to 
determine the protein composition of chromosome scaffolds in DT40 cells. Using 
quantitative proteomics, we identified proteins in the histone-depleted mitotic 
chromosome fraction, which were associated with the mitotic chromosome scaffold, 
including those not previously reported as scaffold components. One of them, BAZ1B, 
has been shown to serve as a transcription factor or tyrosine kinase (24, 25). 
Consistent with our findings, BAZ1B and BAZ1A were shown to be abundant in mitotic 
chromosomes assembled in Xenopus egg extracts (14, 28). 
BAZ1B localization to chromosomal axes in mitosis confirmed the results of 
quantitative proteomics obtained herein. Although BAZ1B KO was not fatal, it 
decreased cell growth, and the effect was stronger for cells with double KO of BAZ1A 
and BAZ1B, suggesting that both BAZ1 proteins have similar functions. The 
chromosomal localization of GFP-tagged BAZ1A in mitosis was difficult to determine, 
but immunoblotting using isolated mitotic chromosomes clearly demonstrated 
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chromosomal association of endogenous BAZ1A in mitosis. However, BAZ1A/B 
double-KO cells did not exhibit a clear mitotic phenotype. In a cell-free system based 
on Xenopus egg extracts, depletion of SMARCA5/ISWI, which forms a complex with 
both BAZ1A and BAZ1B, affected nucleosome spacing but not chromosome assembly 
(28). This study suggested that the SMARCA5-BAZ1 complex enhances proper 
interactions between chromatin and proteins involved in mitotic chromosome 
structure by catalyzing their nucleosomal fluidity (28). Our results also revealed a 
longer duration between phosphorylation of H3pS10 in whole nuclei and complete 
chromosome condensation in BAZ1B KO or BAZ1A/B double-KO cells. Based on these 
findings, we propose a model in which BAZ1 proteins expeditiously enhance chromatin 
association of other chromosome scaffold proteins in early prophase by regulating 
nucleosome spacing. This model is supported by the localization of BAZ1A and BAZ1B 
to the nuclei before mitotic entry. However, our proteomic and immunofluorescence 
analyses suggest an independent association between BAZ1A/B and known 
chromosome scaffold proteins such as condensin, TOP2A, and KIF4. Thus, the lack of 
BAZ1A and BAZ1B caused chromosome condensation delay, which could be recovered 
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until prometaphase. These findings implied that the function of BAZ1 proteins involves 
regulation of proper chromosome condensation timing after phosphorylation of 
histone H3S10 rather than organizing mitotic chromosome structure; however, 
chromosome missegregation was detectable in BAZ1A and BAZ1B double-KO cells at 
the end of anaphase. BAZ1A/B double-KO cells demonstrated segregation errors in 
anaphase, which were similar to those reported in cells lacking condensin I or II (11, 
13, 57). Moreover, IMS assay showed a slight increase in partially abnormal mitotic 
chromosome structure in prophase. This discrepancy suggested the possibility of an 
abnormality in mitotic chromosome structure of BAZ1A/B KO cells that was 
undetectable in this study. 
 We were unable to identify tyrosine residues whose phosphorylation levels 
were decreased in chromosomes of BAZ1B or BAZ1A/B KO cells using quantitative 
phosphoproteomics with HAMMOC, which is likely because of difficulties in detecting 
histone modifications by chromatin proteomics based on trypsin digestion (58). In 
future studies, putative histone phospho-tyrosine residues other than pTyr142 in 
H2A.X should be investigated. Further research should focus on the mechanisms 
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underlying phosphorylation-dependent regulation of mitotic chromosome segregation 
and BAZ1 control of chromosome condensation at mitotic entry through cooperation 
with other components in the mitotic chromosome scaffold. 
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Figure legends 	
Fig. 1. Proteomics of proteins concentrated in the mitotic chromosome 
scaffold. (A) Chromosomes, histone-depleted mitotic chromosomes, or histone-
enriched (soluble) fraction isolated with (+) or without (-) 1% b-mercaptoethanol 
(bME) from DT40 cells were analyzed by immunoblotting using antibodies against 
SMC2, Top2A, or INCENP and Coomassie Brilliant Blue (CBB) staining for core histones. 
Each sample corresponded to the same number of isolated chromosomes. (B) 
Identification of 511 overlapped proteins in SILAC forward versus reverse labeling 
experiments comparing histone-depleted mitotic chromosomes isolated with and 
without bME addition. (C) Identification of 352 overlapped proteins in forward versus 
reverse labeling experiments comparing histone-depleted mitotic chromosomes and 
total mitotic chromosomes. (D) Chromosomes, histone-depleted mitotic 
chromosomes, or soluble fraction isolated with (+) or without (-) 1% bME  from HeLa 
cells were analyzed by immunoblotting using antibodies against TOP2A, BAZ1B, or 
BAZ1A and by CBB staining. Each sample corresponded to the same number of 
isolated chromosomes. (E, F) GFP-b-glucuronidase (GFP-Gus, E) and GFP-BAZ1B (F) 
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were expressed in human epithelial U2OS cells and analyzed for intracellular 
localization; (a, b) metaphase and (c) anaphase. GFP-BAZ1B and GFP-Gus are shown 
in green, and DAPI-stained nuclei are red. Scale bars, 5 µm. High-magnification 
immunofluorescence images of white boxes are on the right. 
 
Fig. 2. Characterization of BAZ1B knockout cells in mitosis. (A) Wild-type (WT), 
BAZ1A knockout (KO), BAZ1B KO, or BAZ1A/B double-KO cell extracts were analyzed 
by immunoblotting using antibodies against BAZ1A, BAZ1B, or GAPDH. (B) Doubling 
time of WT and KO cells and BAZ1B KO and BAZ1A/B double-KO cells expressing GFP-
BAZ1B based on growth curves shown in Fig. S3A. (C) Subdomain comparison 
between BAZ1A and BAZ1B (WAC: WSTF/Acf1/cbpq46 domain; DTT: DNA-binding 
homeobox and different transcription factor motifs; W1, W2, or W3: WAKZ motif 1, 
2, or 3, respectively; PHD: PHD zinc finger; BR: bromodomain). (D) Mitotic profiles 
of WT and KO cells; immunofluorescence images show chromosome morphology in 
each phase (blue, DAPI; green, histone H3pS10; red, a-tubulin). (E) Mitotic profiles 
of WT and KO cells treated with monastrol or MG132 after monastrol release. (F) 
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Frequency of chromosome missegregation in anaphase of WT and KO cells. (G) 
Chromosome missegregation in anaphase of BAZ1A/B double-KO cells. (H) Mitosis 
duration was measured as the time from estimated nuclear envelope breakdown 
(NEB) until anaphase onset based on time-lapse imaging data. (I) Time-lapse imaging 
of histone H2B-mRFP-expressing WT and KO cells. Green or pink arrowheads mark 
estimated NEB or anaphase onsets, respectively. Time from estimated NEB onset (0’) 
is shown. Yellow arrowheads mark bridged chromosomes. (J) Chromosome 
missegregation was quantified as the number of anaphase events with lagging or 
bridged chromosomes divided by the total number of anaphase events based on time-
lapse images. All data are presented as the mean ± SD; *p < 0.05, **p < 0.01, and 
***p < 0.005 calculated by Welch's t-test (n, number of repeated experiments; N, 
total sample number). 
 
Fig. 3. Delay of chromosomal condensation timing in BAZ1A/B double-
knockout cells in prophase. (A) Cartoon depicting changes in nuclear or 
chromosome morphology and phosphorylation level of H3pS10 (green) through 
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prophase determined in this study. (B, C) Three types of prophase chromosomes in 
wild-type (WT, B) and BAZ1A/B double-knockout (KO, C) cells. Histone H3 
phosphorylated at Ser10 and DAPI-stained nuclei are shown. Scale bars, 5 µm. (D) 
Semi-quantitative analysis of the proportion of cells with prophase chromosome types 
shown in (A-C). (E) Semi-quantitative analysis of the proportion of cells with prophase 
chromosome types in WT and KO groups at 10, 20, or 30 min after RO-3306 release. 
The data are presented as the mean ± SD; *p < 0.05 and **p < 0.01; n.s., not 
significant (n, number of repeated experiments; N, total sample number). 
 
Fig. 4 Effects of BAZ1 on mitotic chromosome structures. (A, B) Volcano plots 
of MS data comparing protein abundance ratios in mitotic chromosomes isolated from 
wild-type (WT) and BAZ1B knockout (KO) cells (A) and WT and BAZ1A/B double-KO 
cells (B). (C) Immunofluorescence images of WT and BAZ1A/B double-KO cells 
stained with Ki-67 antibodies and DAPI. High-magnification images of white boxes 
are presented on the right. Scale bar, 5 µm. (D) Quantification of Ki-67 presence on 
mitotic chromosomes of WT, BAZ1B KO, and BAZ1A/B double-KO cells based on 
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images shown in (C). Red lines represent average values. (E) Immunofluorescence 
images of WT, BAZ1A KO, BAZ1B KO, and BAZ1A/B double-KO cells stained with 
TOP2A and CAP-G antibodies and DAPI. High-magnification images of white boxes are 
presented on the right. Scale bar, 5 µm. (F) Strategy for quantification of 
chromosomal axis components using immunofluorescence staining. (G) Quantitative 
comparison of CAP-G, CAP-H2, and TOP2A presence in the mitotic chromosome axis 
of WT, BAZ1A KO, BAZ1B KO, and BAZ1A/B double-KO cells. The data are presented 
as the mean ± SD; n.s., not significant.  
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